Kathleen youre watching daybreak a show coming live from new york and hong kong. Haidi we are counting town to asias major market opens. The top stories, asian stocks to start the week under pressure following mixed signals in fridays jobs report. Inflation pressure from the u. S. And china. Will prices are nearing highs for the year after six straight weeks of that. Saudi arabia extending as his Prime Minister says he will not pursue the judicial overhaul. Annabelle asian stocks are starting the week under pressure and we see futures to a weaker start. We are one hour out from the open in sydney and tokyo. Looking at key events on the horizon the u. S. Rally evaporated at the end of last week. We will have more on that in a moment but in asia key events include Consumer Prices data from china on wednesday. We could see deflation taking hold officially in the country and other factors as well. Japan has got the boj releasing the summary of meeting minutes. Investors will be passing ove
Thank you so much for joining us. Im here today talking with kathleen mcglothlin, whos written an incredibly important and deeply reported book on the blood industry, which is kind of this almost dystopian seeming world. But its a huge economy and industry here in the United States. And kathleen, i wondered if you could start by telling us a bit about your own personal connection to this industry . Of course. So its really nice to be here with you. My interest in the blood plasma industry began about 20 years ago when i was diagnosed with a rare autoimmune disease, and the treatment for that illness is a medication that is made from pieces of human blood plasma. So its called intravenous human immuno globin or ivig for short. I think most people whove never had to take it have never heard of it. Maybe its not a common drug, but it is made from other peoples blood plasma and so for about 20 years, often on, i have been having regular infusions of this medication. And it takes a long tim
Thank you so much for joining us. Im here today talking with kathleen mcglothlin, whos written an incredibly important and deeply reported book on the blood industry, which is kind of this almost dystopian seeming world. But its a huge economy and industry here in the United States. And kathleen, i wondered if you could start by telling us a bit about your own personal connection to this industry . Of course. So its really nice to be here with you. My interest in the blood plasma industry began about 20 years ago when i was diagnosed with a rare autoimmune disease, and the treatment for that illness is a medication that is made from pieces of human blood plasma. So its called intravenous human immuno globin or ivig for short. I think most people whove never had to take it have never heard of it. Maybe its not a common drug, but it is made from other peoples blood plasma and so for about 20 years, often on, i have been having regular infusions of this medication. And it takes a long tim
Surveillance state. Your new book. Im super excited to host is because josh and i were a longtime colleagues at the wall street journal and china. So first things first, a couple of housekeeping rules before we get into the meat of the audience, before we start. If you do have questions, do the event please submit them through the q a function and well get to them in the second half of the event. And of course, more importantly, copies of surveillance state are available for purchase to our bookselling partner, solid state books and you can find a link to buy a book on this page. So just click on that. A quick introduction for our two speakers josh chin is a new america fellow in 2020. Hes also the Deputy Bureau chief in china. The wall street journal. As i mentioned, he previously he and i were previously colleagues there in china. And he has, of course, gone on to do huge, huge things, including being investigated of team that won the loeb awards for International Reporting for a ser
Hi. Thank you so much for joining us. Im here today talking with kathleen mcglothlin, whos written an incredibly important and deeply reported book on the blood industry, which is kind of th almost dystopian seeming world. But its a huge economy and industry here in the United States. And kathleen, i wondered if you could start by telling us a bit about your own personal connection to this industry . Of course. So its really nice to be here with you. My interest in the blood plasma industry began about 20 years ago when i was diagnosed with a rare autoimmune disease, and the treatment for that illness is a medication that is made from pieces of human blood plasma. So its called intravenous human immuno globin or ivig for short. I think most people whove never had to take it have never heard of it. Maybe its not a common drug, but it is made from other peoples blood plasma and so for about 20 years, often on, i have been having regular infusions of this medication. And it takes a long t